Anaheim Bio
Latest round
- Series A
Last raised
- Nov 2026
Total raised
- $45M
Investors
- 6
About Anaheim Bio
Leiden-based Anaheim Bio launched with an oversubscribed €40 million Series A to advance ANA-1, a small molecule candidate for calcium pyrophosphate deposition disease, into the clinic.
Who invested in Anaheim Bio
6 investors across 1 round
See all investors in Anaheim Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 5, 2026
Amount
$45M
Investors
Questions about Anaheim Bio
Who invested in Anaheim Bio?
Anaheim Bio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anaheim Bio raised?
Anaheim Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Anaheim Bio last raise money?
Anaheim Bio's most recent round on record is a Series A, in Nov 2026.
What does Anaheim Bio do?
Leiden-based Anaheim Bio launched with an oversubscribed €40 million Series A to advance ANA-1, a small molecule candidate for calcium pyrophosphate deposition disease, into the clinic.
Where is Anaheim Bio headquartered?
Anaheim Bio is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Anaheim Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back health & biotech companies at Anaheim Bio's stage. Their profiles are linked below.
VCs backing health & biotech startups at Series A
Raising like Anaheim Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.